Your session is about to expire
← Back to Search
Chatbot
Can Mental Health Chatbots Help Chronic Disease Populations?
N/A
Waitlist Available
Led By Luke MacNeill, PhD
Research Sponsored by Luke MacNeill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants are assessed at baseline, two weeks into the study, and four weeks into the study.
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if an A.I. mental health chatbot called Wysa can help people with diabetes or arthritis feel better mentally. The chatbot talks to users and guides them through activities to improve their mood and reduce stress.
Eligible Conditions
- Depression
- Fungal Arthritis
- Arthritis
- Diabetes
- Botox
- Stress
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ participants are assessed at baseline, two weeks into the study, and four weeks into the study.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants are assessed at baseline, two weeks into the study, and four weeks into the study.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in Anxiety as Measured by the Generalized Anxiety Disorder Scale (GAD-7)
Changes in Depression as Measured by the Patient Health Questionnaire (PHQ-9)
Changes in Stress as Measured by the Perceived Stress Scale (PSS-10)
Secondary study objectives
Changes in Life Satisfaction as Measured by the Satisfaction With Life Scale
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment Group (Wysa)Experimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Wysa
2021
N/A
~370
Find a Location
Who is running the clinical trial?
New Brunswick Innovation FoundationUNKNOWN
1 Previous Clinical Trials
150 Total Patients Enrolled
Touchkin eServices Private LimitedUNKNOWN
Luke MacNeillLead Sponsor
Luke MacNeill, PhDPrincipal InvestigatorCentre for Research in Integrated Care, University of New Brunswick